Compare LGND & ASAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LGND | ASAN |
|---|---|---|
| Founded | 1987 | 2008 |
| Country | United States | United States |
| Employees | 68 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.4B |
| IPO Year | N/A | 2020 |
| Metric | LGND | ASAN |
|---|---|---|
| Price | $201.74 | $7.94 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 14 |
| Target Price | ★ $245.17 | $12.62 |
| AVG Volume (30 Days) | 155.0K | ★ 6.5M |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 5.13 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $723,876,000.00 |
| Revenue This Year | $0.74 | $10.53 |
| Revenue Next Year | $19.04 | $9.03 |
| P/E Ratio | $76.27 | ★ N/A |
| Revenue Growth | N/A | ★ 10.94 |
| 52 Week Low | $93.58 | $6.51 |
| 52 Week High | $212.49 | $19.00 |
| Indicator | LGND | ASAN |
|---|---|---|
| Relative Strength Index (RSI) | 57.47 | 43.53 |
| Support Level | $198.52 | $7.15 |
| Resistance Level | $207.72 | $15.44 |
| Average True Range (ATR) | 8.10 | 0.50 |
| MACD | 2.09 | 0.25 |
| Stochastic Oscillator | 75.45 | 84.32 |
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Asana is a work management platform that allows for increased collaboration and visibility across an organization. Delivered via a SaaS-based model, users can track progress across marketing and development initiatives, create and automate workflows, and manage IT approvals. Revenue is generated on a per-seat basis across several pricing tiers. As of fiscal 2025, the company had over 175,000 customers.